Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities.

The World Allergy Organization journal·2026
Same author

Endotypes in chronic spontaneous urticaria.

The Journal of allergy and clinical immunology·2026
Same author

Chronic Urticaria: The Long and Winding Road.

The journal of allergy and clinical immunology. In practice·2026
Same author

Alzheimer's Disease: In Vitro and In Vivo Evidence of Activation of the Plasma Bradykinin-Forming Cascade and Implications for Therapy.

Cells·2025
Same author

An algorithm for the diagnosis, pathogenesis and treatment of chronic spontaneous urticaria, 2024 update.

Allergy·2024
Same author

The bradykinin-forming cascade in anaphylaxis and ACE-inhibitor induced angioedema/airway obstruction.

Frontiers in allergy·2024

Related Experiment Video

Updated: Jul 19, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Chronic urticaria: pathogenesis and treatment.

Allen P Kaplan1

  • 1Department of Medicine, Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina, Charleston, SC 92425, USA. kaplana@musc.edu

The Journal of Allergy and Clinical Immunology
|September 10, 2004
PubMed
Summary

Chronic idiopathic urticaria is now classified into autoimmune and idiopathic subtypes. Autoimmune chronic urticaria involves IgG antibodies targeting IgE receptors or IgE, often linked to antithyroid antibodies, and requires specific treatment strategies.

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

Related Experiment Videos

Last Updated: Jul 19, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

Area of Science:

  • Immunology
  • Dermatology
  • Allergy

Background:

  • Chronic idiopathic urticaria (CIU) is reclassified into chronic autoimmune urticaria (CAU) and chronic idiopathic urticaria (CIU).
  • Approximately 40-50% of CIU patients are now identified with CAU.
  • Both conditions can present with concomitant angioedema in about 40% of cases.

Purpose of the Study:

  • To delineate the immunological mechanisms underlying chronic urticaria subtypes.
  • To identify specific autoantibodies and cellular infiltrates involved in CAU.
  • To outline therapeutic approaches for severe chronic urticaria.

Main Methods:

  • Immunological assays to detect IgG antibodies against IgE receptors and IgE.
  • Histological examination of skin biopsies to analyze cellular infiltrates (CD4+ lymphocytes, monocytes, neutrophils, eosinophils, basophils).
  • Assessment of complement activation pathways (C5a) and cytokine/chemokine involvement.

Main Results:

  • CAU is associated with antithyroid antibodies and pathogenic IgG subclasses (IgG1, IgG3, IgG4) targeting the IgE receptor alpha subunit or IgE.
  • Complement activation via C5a contributes to histamine release.
  • Histology reveals perivascular infiltrates of T(H)1/T(H)2 lymphocytes, monocytes, and inflammatory cells.

Conclusions:

  • Chronic urticaria encompasses distinct autoimmune and idiopathic forms with different underlying mechanisms.
  • Autoantibodies, complement activation, and specific cellular infiltrates are key in CAU pathogenesis.
  • Treatment strategies should be tailored, with severe cases potentially requiring high-dose antihistamines, H-2 antagonists, leukotriene antagonists, or immunosuppressants like cyclosporine.